 |
|
|
| |
Understanding the Resistance Profile of the HIV-1 NNRTI
Doravirine in Combination With the Novel NRTTI MK-8591
|
| |
| |
Reported by Jules Levin
22nd International AIDS Conference; Amsterdam, The Netherlands; 23-27 July 2018.
Daria J. Hazuda1; Min Xu2; Winnie Ngo1; Meizhen Feng1; Carey Hwang3; Jay A. Grobler1; Ming-Tain Lai1
1Department of Antiviral Research, 2Department of Pharmacology, 3Department of Clinical Research, Merck Research Laboratories (West Point, PA), Merck & Co., Inc., Kenilworth, NJ, USA
|
| |
|
|
|
|
|
